Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in HR-NBL Patients

Full title: Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in HR-NBLigh-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study

Morini M, Cangelosi D, Segalerba D, Marimpietri D, Raggi F, Castellano A, Fruci D, de Mora JF, Cañete A, Yáñez Y, Viprey V, Corrias MV, Carlini B, Pezzolo A, Schleiermacher G, Mazzocco K, Ladenstein R, Sementa AR, Conte M, Garaventa A, Burchill S, Luksch R, Bosco MC, Eva A, Varesio L.

Cancers (Basel). 2019 Sep 30;11(10):1476. doi: 10.3390/cancers11101476. PMID: 31575060; PMCID: PMC6826693.

Previous
Previous

Anti-GD2 antibodies in treatment of high-risk Neuroblastoma: present and perspectives

Next
Next

Population pharmacokinetics of carboplatin, etoposide and melphalan in children: …